Pharma and Biotech Latest Insights

Pharma and Biotech

New Vaccine to Protect People in the EU and Worldwide against Dengue

On 13 October 2022, the Committee for Medicinal Products for Human Use (CHMP) of the...

Read more

Pharma and Biotech

Japan to Consider Allowing Import, and Use of Medical Cannabis

Cannabis products for medicinal use may be allowed to be imported and used in Japan...

Read more

Pharma and Biotech

Australia: Import, Advertising and Supply Compliance Priorities 2022-23

The TGA has published a list of import, advertising, and supply compliance priorities from I...

Read more

Pharma and Biotech

TGA Guidance on Application of the Therapeutic Goods Advertising Code 2021

The Therapeutic Goods Advertising Code (TGAC) was amended in November 2021 by the Therapeutic Goods...

Read more

Pharma and Biotech

Thailand Published Draft on the Requirements of GMP Clearance Letter for Ov…

This regulation prescribes guidelines, procedures, and conditions for issuing the GMP Clearance letter for the...

Read more

Pharma and Biotech

Switzerland to Loosen Restrictions on Medical Cannabis

On June 22, 2022, the Switzerland government announced the amendment to the Swiss Narcotics Act,...

Read more

Pharma and Biotech

Singapore HSA Updated the Guidance on Therapeutic Product Registration

They revised checklists for post-approval minor variations (MIV-1 and MIV-2) with: Re-categorisation from MIV-2 Notification...

Read more

Pharma and Biotech

Maldives Issued a Guideline on Registration of Nutraceuticals

On 1 March 2022, The Maldives Food and Drug Authority (MFDA) issued a ‘Guideline on...

Read more

Pharma and Biotech

Australia TGA Updates Requirements for Medicinal Cannabis

In March 2022, TGA published details about the reforms to Medicinal Cannabis Products in Australia,...

Read more

Pharma and Biotech

Philippines FDA Informs about Marketing Authorization of Veterinary Drugs, …

The Philippines FDA informs all establishments and stakeholders that…

Read more